1. Home
  2. RWT vs MESO Comparison

RWT vs MESO Comparison

Compare RWT & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RWT
  • MESO
  • Stock Information
  • Founded
  • RWT 1994
  • MESO 2004
  • Country
  • RWT United States
  • MESO Australia
  • Employees
  • RWT N/A
  • MESO N/A
  • Industry
  • RWT Real Estate Investment Trusts
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RWT Real Estate
  • MESO Health Care
  • Exchange
  • RWT Nasdaq
  • MESO Nasdaq
  • Market Cap
  • RWT 1.0B
  • MESO 1.1B
  • IPO Year
  • RWT 1995
  • MESO N/A
  • Fundamental
  • Price
  • RWT $7.07
  • MESO $10.04
  • Analyst Decision
  • RWT Buy
  • MESO Strong Buy
  • Analyst Count
  • RWT 12
  • MESO 4
  • Target Price
  • RWT $8.10
  • MESO $11.50
  • AVG Volume (30 Days)
  • RWT 893.8K
  • MESO 204.9K
  • Earning Date
  • RWT 10-30-2024
  • MESO 08-28-2024
  • Dividend Yield
  • RWT 9.63%
  • MESO N/A
  • EPS Growth
  • RWT N/A
  • MESO N/A
  • EPS
  • RWT 0.55
  • MESO N/A
  • Revenue
  • RWT $268,358,000.00
  • MESO $5,902,000.00
  • Revenue This Year
  • RWT N/A
  • MESO $66.05
  • Revenue Next Year
  • RWT $19.05
  • MESO $348.27
  • P/E Ratio
  • RWT $12.95
  • MESO N/A
  • Revenue Growth
  • RWT 234.24
  • MESO N/A
  • 52 Week Low
  • RWT $5.46
  • MESO $1.61
  • 52 Week High
  • RWT $8.15
  • MESO $12.18
  • Technical
  • Relative Strength Index (RSI)
  • RWT 37.51
  • MESO 55.85
  • Support Level
  • RWT $7.06
  • MESO $8.52
  • Resistance Level
  • RWT $7.44
  • MESO $12.18
  • Average True Range (ATR)
  • RWT 0.22
  • MESO 0.63
  • MACD
  • RWT -0.03
  • MESO 0.17
  • Stochastic Oscillator
  • RWT 6.08
  • MESO 57.96

About RWT Redwood Trust Inc.

Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: the Residential Consumer Mortgage Banking segment consists of a mortgage loan conduit that acquires residential loans from third-party originators for subsequent sale to whole loan buyers, securitization through SEMT (Sequoia) private-label securitization program, or transfer into its investment portfolio, Residential Investor Mortgage Banking segment consists of a platform that originates and acquires business purpose lending loans for subsequent securitization, sale, or transfers into its investment portfolio, and Investment Portfolio segment consists of organic investments sourced through residential and business-purpose mortgage banking operations.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: